F signal of 50 µM (black) of isolated compound 1 (A) and compound 16 (B) are compared with the spectra of 50 µM (blue), 12.5 µM (magenta) and 6.25 µM (red) of the compounds in the presence of 5 µM enzyme. Spectra in the presence of the enzyme have been scaled by a factor of 4 compared to the spectra of the free compounds. IDE is a well-established protease capable of degrading Aβ 1 as well as the amyloid precursor protein intracellular domain (AICD) 2 . Endogenously secreted Aβ 1-40 is significantly elevated in primary neuronal cultures from ide KO 3 . We thus measured the effect of 1 and 10 on Aβ 1-40 accumulation in cultured human SY5Y neuroblastoma cells. Our ELISA data revealed significant elevations of the peptide in the culture treated with 1, but not with 10, a 100 fold less active analog. This confirms the inhibitory effect of 1 on IDE activity in cell culture. Glucose-Stimulated Insulin Secretion on islets from C57BL/6J wt and Ide-/-mice. Islets isolated from C57BL/6J wild type (a, b) and Ide KO (c, d) were treated successively with 2.8 and 28 mM glucose, in the presence of compound 1 at 3 or 10µM (blue bars) or vehicle (grey bars). The concentrations of insulin (µg/L) in supernatants were then measured after 1 hour incubation time using ELISA. Data are expressed as means of two measurements. Insulin secretion indexes (e) were calculated as the ratio of concentrations of insulin measured at 28mM glucose to the concentrations measured at 2.8 mM for each treatment condition (blue bars for compound 1, grey bars for vehicle). Data shown are mean +/-s.e.m (n=3). propargylamine and acyl-or sulfonyl-chlorides respectively (5a-ad, 6a-y, Scheme S1 and Supplementary methods) and 35 commercial alkynes 7a-7ai. c The 90 alkynes were sorted in 2 orthogonal partitions (X and Y).
Clusters X result from sorting the alkynes by the type of linker, while clusters Y result from sorting the alkynes by the type of R-group. No isobar compounds were within the same cluster. Partition X contains 9 clusters (X1 to X9) of 10 alkynes each, while partition Y contains 10 clusters (Y1 to Y10) of 9 alkynes each. A given cluster of partition X shares only one alkyne in common with any cluster of partition Y. Each alkyne is used in two different competing environments in the TGS experiment. All this is made to maximize the chance of forming and detecting all the binding triazoles amongst the possible combinations. Y2   Y3   Y4   Y5   Y6   Y7   Y8   Y9   Y10   X1  X2  X3  X4  X5  X6  X7  X8 
Y1
X9 S N H O O O 6v S S O O N H 6u S N H O O O N H F 3 C 6w S N H O O N S 6y O N H 5c N H O 5d N H O 5i N H O 5f O N H NC 5g O N H 5a N H O 5b N H O 5j N H O F 3 C 5h N S N H O 5m O O N H 5n O N H 5s O N H 5p S N H O 5o O N H MeO 5q N H O 5k N H O 5l O N H 5t F O N H 5r N H O 5v N H 2 O N H N H 2 5ad O N H 5aa O N H 5x N H O 5w N H O 5y S N H O O 6a N H O 5u BocNH O N H BocNH 5ab N Cl O N H 5z S N H O O F 2 CO 6m S N H O O nPr 6n O S O O N H 6s S N H O O 6p S S N H O O 6o S N H O O nBuO 6q F 3 C S N H O O 6k S N H O O 6l S N H O O N O 6t S O O N H F 3 C 6r S N H O O F 6x N O N S O O N H 6d S O O S N H O O 6i S N H O O 6f S N H O O S 6e F S N H O O 6g S N H O O 6b S O O N H 6c S N H O O O N 6j S N H O O F 3 C 6h O N N H O 5ac 7a N 7c N 7d 7e 7f 7g N N 7h O O H NH 2 7i 7j 7k 7b F 7l O H 7m OH 7n O H 7o 7p OH 7q N 7r S N O O 7s 7t nBuO 7v O 7w MeO 7x N 7y OH 7z MeO 7aa 7u N 7ab N 7ac 7ad nPr 7ae F F 7af O OH 7ag O H O 7ai MeO 7ah N H O Data Collection Beamline APS-19ID APS 19ID APS-19ID
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Supplementary Methods.
All reagents, solvents and starting materials were purchased from commercial suppliers and used without further purification. Melting points were determined using a Büchi B-540 melting point apparatus and are uncorrected. 
S18 N-[1-((R)-2-Hydroxycarbamoyl-1-naphthalen-2-ylmethyl-ethyl)-1H-[1,2,3]triazol-4-ylmethyl]-4-methylbenzamide (3).

Cyclohexanecarboxylic acid [1-(R-2-hydroxycarbamoyl-1-naphthalen-2-ylmethyl-ethyl)-1H-[1,2,3]triazol-4-ylmethyl]-amide (5).
Beige solid (25 mg, 51%), Purity: 95%, mp 176.6-177.9 °C, LC t R = 2. 
N-[1-(1-Hydroxycarbamoylmethyl-2-phenyl-ethyl)-1H-[1,2,3]triazol-4-ylmethyl]-4-methyl-benzamide (10).
White solid (20 mg, 54%), Purity: 97%, LC t R = 2. 
N-[1-(1-Hydroxycarbamoylmethyl-2-phenyl-ethyl)-1H-[1,2,3]triazol-4-ylmethyl]-4-fluoro-benzamide (19).
White solid (15 mg, 15% 
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and concentrated. The resulting monoacid was dissolved and EtOH (24 mL) and aqueous NaOH (2 M, 48 mL)
were added. The resultant mixture was stirred under reflux for 16 h, followed by evaporation of the EtOH under reduced pressure. Extra H 2 O (60 mL) and NaOH (2 M, 10 mL) was added and the mixture was washed with EtOAc (360 mL). Next, the aqueous layer was acidified (pH1) with 1 M HCl, extracted with EtOAc (2120 mL) and the organic layers were dried (MgSO 4 ) and concentrated. 
4-fluoro-N-(N-hydroxycarbamimidoylmethyl)-benzamide (23) (yield = 95%
S21
1H, NH), 7.97-7.92 (m, 2H), 7.29 (t, J = 9.0 Hz, 2H), 5.39 (br s, 2H, NH 2 ), 3.85 (d, J = 6.0 Hz, 2H). 13 C NMR (DMSO-d6) δ: 166.1, 162.7, 150.9, 131.0, 130.4 (d, J C-F = 9 Hz), 115.6 (d, J C-F = 22 Hz), 45.9.
To a solution of 21 (1 eq) in DCM was added carbonyldiimidazole (2.2 eq). The reaction mixture was stirred at room temperature for 10 min. N-hydroxy amidine (1 eq) (22 or 23) was added and the solution was stirred at room temperature for 16 h. The solvent was removed by evaporation in vacuo, and the residue was dissolved in
EtOAc and washed twice with water. The organic layer was dried (MgSO 4 ) and the solvent was removed by evaporation in vacuo. The residue was solubilized in DMF and the solution was heated to reflux for 4 h. The reaction mixture was cooled to room temperature, the solvent was removed by evaporation in vacuo, and the residue was dissolved in EtOAc and washed twice with water. The organic layer was dried (MgSO 4 ) and the solvent was removed by evaporation in vacuo. The oil was purified by flash chromatography on silica gel (cyclohexane/EtOAc 1:0 to 1:1 (v/v)) to afford oxadiazole as a colorless oil. The resulting ester was dissolved and EtOH (24 mL) and aqueous NaOH (2 M) was added. The resultant mixture was stirred under reflux for 16 h, 
S22
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Synthesis of compounds 13-15.
The azide 20c-e (1 equiv) and the alkyne (1equiv) were dissolved separately in DMSO (100-150µL) then added to a mixture of tBuOH/water (1/1) or directly solubilised in a mixture of DMF/water (1/1). CuSO 4 :5H 2 O (0.1equiv) and sodium ascorbate (1 equiv) were added. After 12 h of stirring at room temperature, the media was filtered. In most cases, concentration of the filtrate, followed by precipitation in water, filtration and washing with ethyl acetate gave a pure product. If necessary, the final triazole was purified by flash chromatography on silica gel (CH 2 Cl 2 /MeOH). 
(R)-4-Fluoro-N-[3-(1-hydroxycarbamoylmethyl-2-naphthalen-2-yl-ethyl)-3H-[1,2,3]triazol-4-ylmethyl]-benzamide (16). (R)-3-(5-Aminomethyl-[1,2,3]triazol-1-yl)-4-naphthalen-2-yl-butyric acid
(0.300 mg, 0.97 mmol) was dissolved in dioxane (2.8 mL) and an aqueous saturated solution of K 2 CO 3 (5.7 mL). The biphasic
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mixture was cooled to 0 °C. A solution of 4-fluoro-benzoyl chloride (0.114 mL, 0.97 mmol) in dioxane (2.8 mL)
was slowly added to the amino acid solution and the reaction was allowed to slowly warm to room temperature. 
(R)-Cyclohexanecarboxylic acid [3-(1-hydroxycarbamoylmethyl-2-naphthalen-2-yl-ethyl)-3H-[1,2,3]triazol-4-ylmethyl]-amide (17). (R)-3-(5-Aminomethyl-[1,2,3]triazol-1-yl)-4-naphthalen-2-yl-butyric acid
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The solvent was evaporated under reduced pressure and the residue was dissolved in CH 2 Cl 2 and washed three times with a 5% NaHCO 3 (aq) solution and once with water. 
(R)-N-hydroxy-4-naphthalen-2-yl-3-{5-[(3-phenyl-propionylamino)-methyl]-[1,2,3]triazol-1-yl}-butyramide (18) (R)-3-(5-Aminomethyl-[1,2,3]triazol-1-yl)-4-naphthalen-2-yl-butyric acid
Synthesis of azide precursors 20a-b
To a stirred solution of the corresponding β-amino acid (11.1 mmol) in methanol (48 mL) was added dropwise thionyl chloride (12 mL) at 0 °C. After stirring at room temperature overnight, the solvent was evaporated and the crude material precipitated in ether to give the methyl ester. Imidazole-1-sulfonyl azide hydrochloride (1. 
Synthesis of azide precursors 20c-e
Imidazole-1-sulfonyl azide hydrochloride (1. 
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7.39-7.37 (dd, Table S1 .
Propargylamine (200 µL, 1.1 equiv) and diisopropylamine (462 µL, 1.2 equiv) were solubilized in dichloromethane (4 mL). The reaction media was cooled down to 0 °C and 4-Methyl-benzoyl chloride (353 µL, 1 equiv) or the corresponding chloride or sulfonylchloride was added dropwise. The reaction was stirred at room temperature overnight. The organic layer was washed with HCl 1N (2x4 mL), with NaHCO 3 5% (2x4 mL), with water (2x4 mL) and with brine (1x4 mL), then dried over MgSO 4 and reduced under pressure to give the product. If necessary deprotection of Boc groups is performed using TFA/DCM (1.5/4) at room temperature during 1.5 h. 
2-Methyl-pentanoic acid prop-2-ynylamide (5a)
.
3-Cyclohexyl-N-prop-2-ynyl-propionamide (5b)
Cyclopentanecarboxylic acid prop-2-ynylamide (5d
4-Cyano-N-prop-2-ynyl-benzamide (5g
2-Methylsulfanyl-N-prop-2-ynyl-nicotinamide (5m)
Furan-2-carboxylic acid prop-2-ynylamide (5n
4-Fluoro-N-prop-2-ynyl-benzamide (5r
2-Phenyl-N-prop-2-ynyl-butyramide (5x
6-Chloro-N-prop-2-ynyl-nicotinamide (5z)
((S)-5-tert-Butoxycarbonylamino-1-prop-2-ynylcarbamoyl-pentyl)-carbamic acid tert-butyl ester (5ab).
Colorless oil (694 mg, 63% 
4-Fluoro-N-prop-2-ynyl-benzenesulfonamide (6g
N-Prop-2-ynyl-C-(4-trifluoromethyl-phenyl)-methanesulfonamide (6h)
C-Methanesulfonyl-N-prop-2-ynyl-methanesulfonamide (6i
4-Difluoromethoxy-N-prop-2-ynyl-benzenesulfonamide (6m
C-(7,7-Dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-N-prop-2-ynyl-methanesulfonamide (6s
4-(2-Oxo-pyrrolidin-1-yl)-N-prop-2-ynyl-benzenesulfonamide (6t).
White powder (327 mg, 82%), Purity: 100%. 
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4-Prop-2-ynylsulfamoyl-N-(2,2,2-trifluoro-ethyl)-benzamide (6w
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Supplementary Scheme S1: Synthesis of alkyne reagents 5a-ad, 6a-y. The introduction of the 1,5-disubstituted pattern by a ring constrained Huisgen cycloaddition. 4 Azido compound was coupled to propargylamine with 4-(4,6-dimethoxy [1, 3, 5] triazin-2-yl)-4-methylmorpholinium chloride (DMTMM) to produce the corresponding alkyne, which could give efficiently the bicyclic triazole by intramolecular thermal cycloaddition. A microwave-assisted lactam hydrolysis under acidic conditions yields 1,5-disubstituted triazole intermediate. Subsequent acylations followed by the introduction of the hydroxamate group via coupling with O-tritylhydroxylamine gave the desired triazoles 16-18 after three steps. 5, 6 
